Bracco, Canon Medical Collaborate to Drive CEUS Adoption in Europe

Event summary

  • Bracco Imaging and Canon Medical Systems Europe are co-hosting a symposium on Contrast-Enhanced Ultrasound (CEUS) at the European Congress of Radiology (ECR) 2026 in Vienna, Austria.
  • The symposium, taking place March 5, 2026, will focus on accelerating CEUS adoption and integration into clinical workflows.
  • Key opinion leaders, including Adrian Lim, Thomas Fischer, and Maija Radzina, will present at the session.
  • The event aims to highlight CEUS’s role in improving diagnostic speed, quality, and efficiency within European radiology departments.

The big picture

The joint symposium signals a renewed push for Contrast-Enhanced Ultrasound (CEUS) adoption in Europe, a modality that has faced challenges in gaining widespread clinical acceptance despite its potential to improve diagnostic accuracy and efficiency. Bracco’s partnership with Canon Medical, a major player in medical imaging, suggests a coordinated strategy to overcome these hurdles and expand the market for CEUS agents and related equipment. This initiative reflects a broader trend toward value-based care and the increasing pressure on radiology departments to optimize workflows and improve patient outcomes.

What we're watching

Market Penetration
The success of the symposium will hinge on its ability to demonstrably shift clinical practice; CEUS adoption has been slower than initially predicted, and this event represents a concerted effort to accelerate that change.
Technological Convergence
Canon Medical's involvement suggests a deeper integration of CEUS technology with existing ultrasound platforms, and the long-term impact of this collaboration on device innovation warrants monitoring.
Reimbursement Landscape
Wider CEUS adoption will require favorable reimbursement policies across European healthcare systems; the symposium’s messaging will likely emphasize cost-effectiveness to influence these decisions.